Position in NTRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,187
+$4,788 QoQ
Shares Held
67
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#732
of 846 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $25,003,469 across 20 Diagnostics & Research names. NTRA ranks #19 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,610 | $12,338,469 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
9,231 | $4,859,567 | |
| 3 | DHR |
Danaher Corp /De/
|
11,797 | $2,247,092 | |
| 4 | ILMN |
Illumina, Inc.
|
11,514 | $2,024,506 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
546 | $697,520 | |
| 6 | A |
Agilent Technologies, Inc.
|
4,187 | $556,159 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
2,084 | $472,630 | |
| 8 | RVTY |
Revvity, Inc.
|
3,686 | $410,104 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,187 | 67 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $13,399 | 67 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $16,265 | 71 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $9,497 | 59 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $9,122 | 54 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $141 | 1 | Shares | Sole | 2025-05-12 | |
| 2024-03-31 | $914 | 10 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||